{"id":"https://openalex.org/W4361944675","doi":"https://doi.org/10.1158/1078-0432.c.6522867","title":"Data from Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen\u2013Specific T-cell Immunity in Head and Neck Cancer Patients","display_name":"Data from Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen\u2013Specific T-cell Immunity in Head and Neck Cancer Patients","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361944675","doi":"https://doi.org/10.1158/1078-0432.c.6522867"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6522867","doi":"https://doi.org/10.1158/1078-0432.c.6522867","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6522867","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6522867","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017163410","display_name":"Raghvendra Mohan Srivastava","orcid":"https://orcid.org/0000-0001-6545-3957","observed_orcids":["https://orcid.org/0000-0001-6545-3957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raghvendra M. Srivastava","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100650756","display_name":"Steve C. Lee","orcid":"https://orcid.org/0000-0002-4460-4303","observed_orcids":["https://orcid.org/0000-0002-4460-4303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve C. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083740731","display_name":"Pedro A. Andrade Filho","orcid":"https://orcid.org/0000-0003-2299-0933","observed_orcids":["https://orcid.org/0000-0003-2299-0933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro A. Andrade Filho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040770058","display_name":"Christopher A. Lord","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher A. Lord","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101198472","display_name":"Hyun-Bae Jie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hyun-Bae Jie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051199971","display_name":"H. Carter Davidson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Carter Davidson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084748116","display_name":"Andr\u00e9s L\u00f3pez\u2010Albaitero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9s L\u00f3pez-Albaitero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047684810","display_name":"Sandra Poveda Gibson","orcid":"https://orcid.org/0000-0002-0707-7102","observed_orcids":["https://orcid.org/0000-0002-0707-7102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra P. Gibson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017526826","display_name":"William E. Gooding","orcid":"https://orcid.org/0000-0001-9070-3559","observed_orcids":["https://orcid.org/0000-0001-9070-3559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William E. Gooding","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028669896","display_name":"Soldano Ferrone","orcid":"https://orcid.org/0000-0003-2900-8834","observed_orcids":["https://orcid.org/0000-0003-2900-8834"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soldano Ferrone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086074491","display_name":"Robert Louis Ferris","orcid":"https://orcid.org/0000-0001-6605-2071","observed_orcids":["https://orcid.org/0000-0001-6605-2071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Ferris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.47850000858306885,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.47850000858306885,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.2874000072479248,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1404000073671341,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9350000023841858},{"id":"https://openalex.org/keywords/dendritic-cell-maturation","display_name":"dendritic cell maturation","score":0.906000018119812},{"id":"https://openalex.org/keywords/fcgammariiia-polymorphism","display_name":"Fc\u03b3RIIIa polymorphism","score":0.9210000038146973},{"id":"https://openalex.org/keywords/cd8-t-cell-priming","display_name":"CD8+ T cell priming","score":0.8100000023841858},{"id":"https://openalex.org/keywords/mage-3","display_name":"MAGE-3","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.7179999947547913},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7139999866485596},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.945639967918396},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.489452987909317},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.46023157238960266},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4413134455680847},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.42587384581565857},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.41350191831588745},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.40038299560546875},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3985975384712219},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3955899178981781},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39076322317123413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3714282512664795},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.35365116596221924},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32919013500213623},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32133352756500244}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6522867","doi":"https://doi.org/10.1158/1078-0432.c.6522867","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6522867","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6522867.v1","doi":"https://doi.org/10.1158/1078-0432.c.6522867.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522867.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6522867","doi":"https://doi.org/10.1158/1078-0432.c.6522867","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6522867","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2163196794","https://openalex.org/W1488353562","https://openalex.org/W2069827107","https://openalex.org/W4361952036","https://openalex.org/W2567281524","https://openalex.org/W2331100598","https://openalex.org/W1992315309","https://openalex.org/W4250823867","https://openalex.org/W2007632544","https://openalex.org/W2088139924"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Tumor":[2],"antigen\u2013specific":[3],"monoclonal":[4],"antibodies":[5],"(mAb)":[6],"block":[7],"oncogenic":[8],"signaling":[9],"and":[10,22,27,56,89,98,143,172,212,221,243],"induce":[11],"Fc\u03b3":[12],"receptor":[13,68],"(Fc\u03b3R)\u2013mediated":[14],"cytotoxicity.":[15],"However,":[16],"the":[17,137,151],"role":[18],"of":[19,79,139,161],"CD8+":[20,118,213],"CTL":[21,194],"Fc\u03b3R":[23],"in":[24,31,50,72,109,123,249],"initiating":[25],"innate":[26],"adaptive":[28,182],"immune":[29,183],"responses":[30,184],"mAb-treated":[32],"human":[33],"patients":[34,53,74,111,125,251],"with":[35,48,54,75,112,126,252],"cancer":[36,58],"is":[37],"still":[38],"emerging.":[39],"Experimental":[40],"Design:":[41],"Fc\u03b3RIIIa":[42,102,144,228],"codon":[43],"158":[44],"polymorphism":[45,103,152,229],"was":[46,62,92,238],"correlated":[47],"survival":[49],"107":[51],"cetuximab-treated":[52,73,110,124,250],"head":[55],"neck":[57],"(HNC).":[59],"Flow":[60],"cytometry":[61],"carried":[63],"out":[64],"to":[65,193,217,235,256],"quantify":[66],"EGF":[67],"(EGFR)\u2013specific":[69],"T":[70,119,247],"cells":[71,120,142,147,157,208,248],"HNC.":[76],"The":[77],"effect":[78],"cetuximab":[80,236],"on":[81,145,150],"natural":[82],"killer":[83],"(NK)":[84],"cell,":[85],"dendritic":[86],"cell":[87,174],"(DC),":[88],"T-cell":[90,214],"activation":[91],"measured":[93],"using":[94],"IFN-\u03b3":[95],"release":[96,224],"assays":[97],"flow":[99],"cytometry.":[100],"Results:":[101],"did":[104,230],"not":[105,149,231],"predict":[106,232],"clinical":[107,233,257],"outcome":[108],"HNC;":[113],"however,":[114],"elevated":[115],"circulating":[116],"EGFR853\u2013861\u2013specific":[117],"were":[121],"found":[122],"HNC":[127,253],"(P":[128],"<":[129],"0.005).":[130],"Cetuximab":[131,180],"promoted":[132],"EGFR-specific":[133,246],"cellular":[134],"immunity":[135],"through":[136,177,225],"interaction":[138,242],"EGFR+":[140],"tumor":[141,202,218],"NK":[146,156,186,207],"but":[148,237],"per":[153],"se.":[154],"Cetuximab-activated":[155,206],"induced":[158],"IFN-\u03b3\u2013dependent":[159],"expression":[160],"DC":[162,188,210],"maturation":[163,211],"markers,":[164],"antigen":[165,219],"processing":[166],"machinery":[167],"components":[168],"such":[169],"as":[170,198,200],"TAP-1/2":[171],"T-helper":[173],"(TH1)":[175],"chemokines":[176],"NKG2D/MICA":[178],"binding.":[179],"initiated":[181],"via":[185],"cell\u2013induced":[187],"maturation,":[189],"which":[190],"enhanced":[191],"cross-presentation":[192],"specific":[195],"for":[196,240],"EGFR":[197],"well":[199],"another":[201],"antigen,":[203],"MAGE-3.":[204],"Conclusion:":[205],"promote":[209],"priming,":[215],"leading":[216],"spreading":[220],"TH1":[222],"cytokine":[223],"\u201cNK\u2013DC":[226],"cross-talk.\u201d":[227],"response":[234],"necessary":[239],"NK\u2013DC":[241],"mAb-induced":[244],"cross-presentation.":[245],"may":[254],"contribute":[255],"response.":[258],"Clin":[259],"Cancer":[260],"Res;":[261],"19(7);":[262],"1858\u201372.":[263],"\u00a92013":[264],"AACR.":[265]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}